Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.64 -0.16 (-0.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Receivables (2010 - 2026)

Updated

Sarepta Therapeutics (SRPT) posted Receivables of $421.82 million for Q2 2026, down 29.8% from $600.6 million a year earlier and down 20.6% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Receivables (2010 - 2026) Analysis & Trends

At the end of FY2025, Sarepta Therapeutics' Receivables came in at $502.33 million, down 21.1% from FY2024.

  • Annual Receivables shows a five-year compound annual growth rate of 30.0% (FY2020 to FY2025).
  • In prior years, Sarepta Therapeutics' Receivables was $636.59 million in FY2024 (+48.0%), $430.13 million in FY2023 (+67.7%), $256.43 million in FY2022 (+49.4%) and $171.59 million in FY2021 (+26.6%).
  • The Q2 2026 figure stands as the lowest quarterly Receivables since Q2 2024.
  • On a year-over-year basis, Receivables has declined in each of the last three quarters, with growth averaging 18.8% over the last eight quarters.
  • The strongest year-over-year quarter for Receivables in the past five years was Q1 2025, with growth of 74.8%; the weakest was Q2 2026, with a decline of 29.8%.
  • According to Business Quant data, Receivables for the three prior quarters was $531.22 million (Q1 2026), $502.33 million (Q4 2025) and $524.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn 421.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 421.82 Mn
Mar 31, 2026 531.22 Mn
Dec 31, 2025 502.33 Mn
Sep 30, 2025 524.44 Mn
Jun 30, 2025 600.60 Mn
Mar 31, 2025 714.57 Mn
Dec 31, 2024 636.59 Mn
Sep 30, 2024 500.92 Mn
Jun 30, 2024 379.90 Mn
Mar 31, 2024 408.91 Mn
Dec 31, 2023 430.13 Mn
Sep 30, 2023 354.26 Mn
Jun 30, 2023 265.41 Mn
Mar 31, 2023 285.84 Mn
Dec 31, 2022 256.43 Mn
Sep 30, 2022 223.41 Mn
Jun 30, 2022 230.25 Mn
Mar 31, 2022 195.89 Mn
Dec 31, 2021 171.59 Mn
Sep 30, 2021 178.89 Mn
API Access

Sarepta Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=SRPT&period=max&api_key=YOUR_API_KEY